EMC Instytut Medyczny SA (EMC.WA)
PLN 10.6
(2.91%)
PLN 10.6
(2.91%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 248.35 Million PLN | 3.26% |
| 2022 | 240.5 Million PLN | 22.11% |
| 2021 | 196.96 Million PLN | 0.44% |
| 2020 | 196.11 Million PLN | -22.3% |
| 2019 | 252.39 Million PLN | 43.48% |
| 2018 | 175.9 Million PLN | 8.61% |
| 2017 | 161.96 Million PLN | 10.7% |
| 2016 | 146.31 Million PLN | 47.04% |
| 2015 | 99.5 Million PLN | -5.6% |
| 2014 | 105.4 Million PLN | 14.1% |
| 2013 | 92.37 Million PLN | 23.24% |
| 2012 | 74.95 Million PLN | -3.35% |
| 2011 | 77.55 Million PLN | 16.77% |
| 2010 | 66.41 Million PLN | 25.79% |
| 2009 | 52.8 Million PLN | 40.64% |
| 2008 | 37.54 Million PLN | 63.18% |
| 2007 | 23 Million PLN | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 253.41 Million PLN | 0.12% |
| 2024 Q1 | 253.1 Million PLN | 1.91% |
| 2023 FY | 248.35 Million PLN | 3.26% |
| 2023 Q3 | 254.73 Million PLN | 5.42% |
| 2023 Q1 | 236.27 Million PLN | -1.76% |
| 2023 Q2 | 241.63 Million PLN | 2.27% |
| 2023 Q4 | 248.35 Million PLN | -2.51% |
| 2022 Q3 | 223.85 Million PLN | 8.41% |
| 2022 Q2 | 206.48 Million PLN | 2.48% |
| 2022 FY | 240.5 Million PLN | 22.11% |
| 2022 Q1 | 201.48 Million PLN | 2.29% |
| 2022 Q4 | 240.5 Million PLN | 7.44% |
| 2021 Q4 | 196.96 Million PLN | -7.58% |
| 2021 FY | 196.96 Million PLN | 0.44% |
| 2021 Q2 | 186.99 Million PLN | -2.71% |
| 2021 Q1 | 192.2 Million PLN | -1.99% |
| 2021 Q3 | 213.11 Million PLN | 13.97% |
| 2020 Q1 | 251.79 Million PLN | -0.24% |
| 2020 Q2 | 264.45 Million PLN | 5.03% |
| 2020 Q3 | 198.48 Million PLN | -24.95% |
| 2020 Q4 | 196.11 Million PLN | -1.2% |
| 2020 FY | 196.11 Million PLN | -22.3% |
| 2019 Q4 | 252.39 Million PLN | 19.94% |
| 2019 FY | 252.39 Million PLN | 43.48% |
| 2019 Q1 | 206.27 Million PLN | 17.26% |
| 2019 Q3 | 210.44 Million PLN | 0.6% |
| 2019 Q2 | 209.18 Million PLN | 1.41% |
| 2018 Q4 | 175.9 Million PLN | 5.28% |
| 2018 FY | 175.9 Million PLN | 8.61% |
| 2018 Q3 | 167.08 Million PLN | -0.49% |
| 2018 Q2 | 167.91 Million PLN | 2.67% |
| 2018 Q1 | 163.54 Million PLN | 0.97% |
| 2017 Q2 | 153.9 Million PLN | 2.26% |
| 2017 FY | 161.96 Million PLN | 10.7% |
| 2017 Q4 | 161.96 Million PLN | 2.71% |
| 2017 Q3 | 157.69 Million PLN | 2.46% |
| 2017 Q1 | 150.51 Million PLN | 2.87% |
| 2016 Q2 | 94.48 Million PLN | -8.23% |
| 2016 FY | 146.31 Million PLN | 47.04% |
| 2016 Q1 | 102.95 Million PLN | 3.47% |
| 2016 Q4 | 146.31 Million PLN | 10.98% |
| 2016 Q3 | 131.83 Million PLN | 39.53% |
| 2015 Q3 | 98.15 Million PLN | -2.79% |
| 2015 Q4 | 99.5 Million PLN | 1.37% |
| 2015 FY | 99.5 Million PLN | -5.6% |
| 2015 Q1 | 105.43 Million PLN | 0.03% |
| 2015 Q2 | 100.97 Million PLN | -4.22% |
| 2014 Q4 | 105.4 Million PLN | -0.17% |
| 2014 FY | 105.4 Million PLN | 14.1% |
| 2014 Q1 | 109.1 Million PLN | 18.11% |
| 2014 Q2 | 112.26 Million PLN | 2.9% |
| 2014 Q3 | 105.57 Million PLN | -5.96% |
| 2013 Q4 | 92.37 Million PLN | -7.18% |
| 2013 FY | 92.37 Million PLN | 23.24% |
| 2013 Q1 | 73.76 Million PLN | -1.59% |
| 2013 Q2 | 75.24 Million PLN | 2.0% |
| 2013 Q3 | 99.52 Million PLN | 32.27% |
| 2012 Q3 | 77.9 Million PLN | 0.46% |
| 2012 Q1 | 76.98 Million PLN | -0.73% |
| 2012 FY | 74.95 Million PLN | -3.35% |
| 2012 Q2 | 77.54 Million PLN | 0.73% |
| 2012 Q4 | 74.95 Million PLN | -3.78% |
| 2011 Q4 | 77.55 Million PLN | -0.81% |
| 2011 Q1 | 77.59 Million PLN | 16.83% |
| 2011 Q2 | 78.12 Million PLN | 0.68% |
| 2011 Q3 | 78.19 Million PLN | 0.09% |
| 2011 FY | 77.55 Million PLN | 16.77% |
| 2010 Q3 | 63.82 Million PLN | 2.42% |
| 2010 FY | 66.41 Million PLN | 25.79% |
| 2010 Q4 | 66.41 Million PLN | 4.07% |
| 2010 Q2 | 62.31 Million PLN | 2.35% |
| 2010 Q1 | 60.88 Million PLN | 15.31% |
| 2009 Q4 | 52.8 Million PLN | 0.0% |
| 2009 FY | 52.8 Million PLN | 40.64% |
| 2008 FY | 37.54 Million PLN | 63.18% |
| 2007 FY | 23 Million PLN | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Centrum Medyczne ENEL-MED S.A. | 315.68 Million PLN | 21.327% |